Bilirubin—A Possible Prognostic Mortality Marker for Patients with ECLS

Extracorporeal life support (ECLS) is a promising therapeutic option for patients with refractory cardiogenic shock. However, as the mortality rate still remains high, there is a need for early outcome parameters reflecting therapy success or futility. Therefore, we investigated whether liver enzyme...

Descripción completa

Detalles Bibliográficos
Autores principales: Bunte, Sebastian, Walz, Roland, Merkel, Julia, Torregroza, Carolin, Roth, Sebastian, Lurati Buse, Giovanna, Dalyanoglu, Hannan, Akhyari, Payam, Lichtenberg, Artur, Hollmann, Markus W., Aubin, Hug, Huhn, Ragnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356548/
https://www.ncbi.nlm.nih.gov/pubmed/32503278
http://dx.doi.org/10.3390/jcm9061727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356548/
https://www.ncbi.nlm.nih.gov/pubmed/32503278
http://dx.doi.org/10.3390/jcm9061727

Ejemplares similares